Fact CheckerSign in

NCT06305390RecruitingPhase 2

Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.

Source: ClinicalTrials.gov · Last updated 1 Apr 2026

Brief summary (registry, in English)

This project aims to evaluate the role of fully hybrid PET/MRI with 18FPSMA and multiparametric MR imaging (mpMRI) as one-stop approach for the diagnosis of clinically significant prostate cancer (csPCa). Our main hypothesis is that adding 18F-PSMA PET to mpMRI prior to biopsy, will reduce the number of false negative findings, while at the same time, allowing also to reduce the number of unnecessary prostate biopsies in patients with low-risk, clinically indolent PCa.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
167 (estimated)
First submitted
5 Mar 2024
Start date
4 Dec 2023
Primary completion date
24 Mar 2026
Lead sponsor
IRCCS San Raffaele
NCT number
NCT06305390

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 167
  • From 4 Dec 2023 to the primary completion date, 24 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior diagnosis of prostate cancer

Lab values

  • Contraindication to MRI (e.g. claustrophobia, pacemaker, estimated GFR lower or equal to 50mls/min)

Other

  • Contraindication to prostate biopsy

Who the study is looking for

  • Men at least 18 years of age referred with clinical suspicion of prostate cancer candidate for prostate biopsy
  • Feasibility to undergo all procedures listed in protocol
  • Ability to provide written informed consent

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
U.O. of Nuclear Medicine, ,Ospedale San Raffaele
Coordinator of this site? Confirm its status
MilanItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.